相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Traditional Cardiovascular Risk Factors and Individual Prediction of Cardiovascular Events in Childhood Cancer Survivors
Yan Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles
Melanie Ricke-Hoch et al.
CARDIOVASCULAR RESEARCH (2020)
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis
Lars Michel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Angina pectoris in a 47-year-old athletic man with psoriasis vulgaris
S. Braumann et al.
INTERNIST (2019)
Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib
Yllka Latifi et al.
BLOOD (2019)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
F. Lynce et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Cardiovascular toxicities associated with immune checkpoint inhibitors
Jiun-Ruey Hu et al.
CARDIOVASCULAR RESEARCH (2019)
Common risk factors for heart failure and cancer
Wouter C. Meijers et al.
CARDIOVASCULAR RESEARCH (2019)
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Maddalena Centanni et al.
CLINICAL PHARMACOKINETICS (2019)
Impacts of non-recovery of trastuzumab-induced cardiomyopathy on clinical outcomes in patients with breast cancer
Hyun Ju Yoon et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Late onset heart failure after childhood chemotherapy
Denise Hilfiker-Kleiner et al.
EUROPEAN HEART JOURNAL (2019)
Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance
Maryam B. Lustberg et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2019)
Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium
Le Jiang et al.
HEART RHYTHM (2019)
Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response
Abdullah Hamadi et al.
THROMBOSIS AND HAEMOSTASIS (2019)
HER2+breast cancer treatment and cardiotoxicity: monitoring and management
Guy Jerusalem et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
P. Kosalka et al.
CURRENT ONCOLOGY (2019)
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Katelyn M. Atkins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
Maya Guglin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy End of One Size Fits All
Ana Barac et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis
Joe-Elie Salem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention
Giovanni Caocci et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F. Cornell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease JACC Scientific Expert Panel
Milind Y. Desai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity
Shorn Goel et al.
JACC-HEART FAILURE (2019)
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
Oscar Calvillo-Arguelles et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer
Omar Abdel-Rahman
CLINICAL COLORECTAL CANCER (2019)
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
Matthias Totzeck et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers
Lara F. Nhola et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2019)
Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL plus acute lymphoblastic leukemia
Michaela Scherr et al.
LEUKEMIA (2019)
Cardiovascular Complications Associated with Mediastinal Radiation
Katherine Lee Chuy et al.
CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2019)
Increased Cancer Prevalence in Peripartum Cardiomyopathy
Tobias J. Pfeffer et al.
JACC: CARDIOONCOLOGY (2019)
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors A Systematic Review and Meta-analysis
Raluca I. Mincu et al.
JAMA NETWORK OPEN (2019)
Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing
Bruno C. Medeiros et al.
BLOOD REVIEWS (2018)
Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome
Lisa M. Tilemann et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Long-term heart-specificmortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study
Janick Weberpals et al.
EUROPEAN HEART JOURNAL (2018)
Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer
Eric J. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Javid J. Moslehi et al.
LANCET (2018)
Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell derived cardiomyocytes
Hyang-Ae Lee et al.
PLOS ONE (2018)
Do radiation oncology outreach clinics affect the use of radiotherapy?
Pierre-Yves McLaughlin et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution
Celine Anquetil et al.
CIRCULATION (2018)
Toxicity of cancer therapy: what the cardiologist needs to know about angiogenesis inhibitors
Stephen J. H. Dobbin et al.
HEART (2018)
Immune checkpoint inhibitors and cardiovascular toxicity
Alexander R. Lyon et al.
LANCET ONCOLOGY (2018)
Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction
Somaira Nowsheen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Long-Term Follow-Up in Childhood Cancer Survivors Position paper 2018 of the working group long-term follow-up of the Society of Pediatric Oncology and Hematology (GPOH) on long-term surveillance, long-term follow-up and late effect evaluation in pediatric oncology patients
Thorsten Langer et al.
KLINISCHE PADIATRIE (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Cardiovascular adverse events in multiple myeloma patients
Markus B. Heckmann et al.
JOURNAL OF THORACIC DISEASE (2018)
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity
Lars Michel et al.
JOURNAL OF THORACIC DISEASE (2018)
Ibrutinib-Associated Atrial Fibrillation
Sarju Ganatra et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2018)
5-fluorouracil and cardiotoxicity: a review
Jaskanwal D. Sara et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari et al.
BLOOD ADVANCES (2018)
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma
Michael G. Fradley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Jason Weatherald et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
Carolyn Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 2
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients? Evidence from a meta-analysis including 55 studies
Hong Sun et al.
MEDICINE (2017)
Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan
Shigeaki Suzuki et al.
NEUROLOGY (2017)
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129
Tzehow Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
Timothy J. Stuhlmiller et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment
Sooraj John et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity
Marion Escudier et al.
CIRCULATION (2017)
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
Andreas D. Meid et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib
Tracy E. Wiczer et al.
BLOOD ADVANCES (2017)
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
Vivek Narayan et al.
CLINICAL CANCER RESEARCH (2017)
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin
Rebeca Rodriguez-Veiga et al.
ANNALS OF HEMATOLOGY (2017)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Moreau et al.
ANNALS OF ONCOLOGY (2017)
Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
John C. Reneau et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Cardiac Diseases Following Childhood Cancer Treatment Cohort Study
Nadia Haddy et al.
CIRCULATION (2016)
'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factors
Sophia Danhof et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
The pathogenesis and treatment of cardiac atrophy in cancer cachexia
Kate T. Murphy
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease
Sarah Parent et al.
CANADIAN JOURNAL OF CARDIOLOGY (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty
Daniel J. Lenihan et al.
JOURNAL OF CARDIAC FAILURE (2016)
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Christophe Guignabert et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Meletios A. Dimopoulos et al.
LANCET ONCOLOGY (2016)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia
Jessica T. Leonard et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
A. Rosenthal et al.
BLOOD CANCER JOURNAL (2016)
Organization and implementation of a cardio-oncology program
Manuela Fiuza et al.
REVISTA PORTUGUESA DE CARDIOLOGIA (2016)
Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large-scale multinational trials (PROFILE 1005 and 1007)
Sai-Hong Ignatius Ou et al.
CANCER MEDICINE (2016)
Novel concepts in radiation-induced cardiovascular disease
Jason R. Cuomo et al.
WORLD JOURNAL OF CARDIOLOGY (2016)
Clinical features of pulmonary arterial hypertension in patients receiving dasatinib
Neil P. Shah et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Chemotherapy-Induced Pulmonary Hypertension Role of Alkylating Agents
Benoit Ranchoux et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors
J. S. L. Kloth et al.
BRITISH JOURNAL OF CANCER (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
Naomi B. Haas et al.
CLINICAL CANCER RESEARCH (2015)
Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Pooja Ghatalia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy
Evandro de Azambuja et al.
EUROPEAN JOURNAL OF CANCER (2015)
Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma
A. Keith Stewart
FUTURE ONCOLOGY (2015)
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Evangelos Terpos et al.
HAEMATOLOGICA (2015)
Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer
Gregory T. Armstrong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Saro H. Armenian et al.
LANCET ONCOLOGY (2015)
European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Evangelos Terpos et al.
HAEMATOLOGICA (2015)
Cardiovascular Disease After Hodgkin Lymphoma Treatment 40-Year Disease Risk
Frederika A. van Nimwegen et al.
JAMA INTERNAL MEDICINE (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P. Ghatalia et al.
BRITISH JOURNAL OF CANCER (2015)
Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia
D. Rea et al.
LEUKEMIA (2015)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
Histone deacetylase signaling in cardioprotection
Lorenz H. Lehmann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease
John D. Groarke et al.
EUROPEAN HEART JOURNAL (2014)
Influence of Conventional Cardiovascular Risk Factors and Lifestyle Characteristics on Cardiovascular Disease After Hematopoietic Cell Transplantation
Eric J. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association
Steven E. Lipshultz et al.
CIRCULATION (2013)
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
David Siegel et al.
HAEMATOLOGICA (2013)
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
Mary S. McCabe et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cardiac Complications of Thoracic Irradiation
Catherine Jaworski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias
J. E. Cortes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
Erik R. Nelson et al.
SCIENCE (2013)
Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes
Kimberly R. Doherty et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2013)
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
Richard M. Steingart et al.
AMERICAN HEART JOURNAL (2012)
Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project
Tanja Stocks et al.
HYPERTENSION (2012)
Late Cardiac Effects of Cancer Treatment
Daniel J. Lenihan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
Erin J. Aiello Bowles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
Smita Bhatia
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Troponin elevation in coronary vs. non-coronary disease
S. Agewall et al.
EUROPEAN HEART JOURNAL (2011)
Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
Barry H. Trachtenberg et al.
PEDIATRIC CARDIOLOGY (2011)
Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib
Dominika Nowis et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Cardiac Function in 5-Year Survivors of Childhood Cancer A Long-term Follow-up Study
Helena J. van der Pal et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Clinical Toxicities of Histone Deacetylase Inhibitors
Srividya Subramanian et al.
PHARMACEUTICALS (2010)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction
Muzaffar H. Qazilbash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
M. A. Dimopoulos et al.
LEUKEMIA (2009)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
Daniel A. Mulrooney et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Late Congestive Heart Failure After Hematopoietic Cell Transplantation
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer
Maartje J. Hooning et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Chronic health conditions in adult survivors of childhood cancer
Kevin C. Oeffinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors
Manisha H. Shah et al.
CLINICAL CANCER RESEARCH (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Bradycardia during therapy for multiple myeloma with thalidomide
IE Fahdi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
O Hequet et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
